ScreenerHero
GLOWGlow LifeTech Corp
CNQ · CA · Healthcare · Biotechnology · glowlifetech.com
0.0450CAD0.00%Mkt Cap: 6.31M $P/E: Infinity

Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-solubl…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap6.31M $
Enterprise Value5.18M $
Revenue (TTM)1.62M $
Gross Profit992.03K $
Net Income (TTM)-449.96K $
Revenue/Share0.0095 USD
Last Price0.0450 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA37989H1091
Valuation
P/E (Trailing)Infinity
P/E (Forward)—
PEG—
EV/EBITDA-15.88
EV/Revenue3.21
P/S3.90
P/B2.65
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.040014% of range0.0750
52W High0.0750 CAD
52W Low0.0400 CAD
Profitability
Gross Margin66.33%
Oper. Margin-10.99%
EBITDA Margin-20.19%
Profit Margin-30.09%
ROE-22.80%
ROA-15.78%
Growth
Revenue Growth34.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.94K $
CapEx (TTM)75.14K $
FCF Margin16.73%
FCF Yield4.29%
Net Debt-1.13M $
Net Debt/EBITDA3.45
Balance Sheet
Debt/Equity0.02
Current Ratio2.70
Quick Ratio1.98
Book Value/Sh0.0170 CAD
Cash/Share0.0080 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.192.44M
Float138.71M
Insiders23.03%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short563
Short (prev mo.)3.81K
Technical
SMA 500.0455 (-1.1%)
SMA 2000.0508 (-11.5%)
Beta1.47
S&P 52W Chg18.16%
Avg Vol (30d)123.03K
Avg Vol (10d)106.79K
Technical Indicators
RSI (14)44.4
MACD-0.0004
MACD Signal-0.0005
MACD Hist.+0.0001
BB Upper0.0450 CAD
BB Middle0.0450 CAD
BB Lower0.0450 CAD
BB Width0.00%
ATR (14)0.0011 CAD
Vol Ratio (20d)0.14x